Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 49 | ECE2017 | Next issue

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

Card image cap
20-23 May 2017, Lisbon, Portugal Further information

Oral Communications

Thyroid Cancer

ea0049oc14.1 | Thyroid Cancer | ECE2017

Anti-Mullerian hormone (AMH) in pre-menopausal females after ablative radioiodine (RAI) treatment for differentiated thyroid cancer (DTC): single-center study

Mittica Miranda , Comite Paola , Campana Claudia , Gay Stefano , Mussap Michele , Giusti Massimo

Background: It is generally reported that female fertility is not affected by high-dose RAI treatment. AMH has been considered a reliable and accurate index of ovarian reserve. There are few data on AMH values in thyroid diseases. Recently, in DTC women who had undergone RAI ablation treatment, Acibucu et al. (2016) reported low AMH levels without significant impairment of fertility.Aim: The aim of this single-center study was to evaluate AMH le...

ea0049oc14.2 | Thyroid Cancer | ECE2017

Suppression of heme oxygenase-1 inhibits growth and invasion of thyroid cancer

Cheng Shih-Ping , Lee Jie-Jen , Chen Ming-Jen , Liu Chien-Liang , Yang Po-Sheng , Hsu Yi-Chiung

Oxidative stress generated in the process of iodide metabolism and thyroid hormone synthesis may play a role in thyroid tumorigenesis and progression of thyroid cancer. The transcription factor Nrf2 is the most important regulator of antioxidant responses. It has been shown that Nrf2 expression is upregulated in papillary thyroid cancer. In response to oxidative stress, nuclear Nrf2 activates antioxidant-responsive elements and induces the expression of stress-responsive genes...

ea0049oc14.3 | Thyroid Cancer | ECE2017

TERT, BRAF and NRAS in the molecular profile of metastatic thyroid cancer: differences between primary and distant disease

Melo Miguel , Gaspar da Rocha Adriana , Batista Rui , Vinagre Joao , Joao Martins Maria , Costa Gracinda , Ribeiro Cristina , Carrilho Francisco , Leite Valeriano , Lobo Claudia , Manuel Cameselle-Teijeiro Jose , Sobrinho-Simoes Manuel , Soares Paula

Context: Little is known about the frequency of key mutations in thyroid cancer metastases and its relationship with the primary tumor genotype.Objectives: To evaluate the frequency of TERT promoter (TERTp), BRAF and NRAS mutations in metastatic thyroid carcinomas, analyzing primary thyroid tumors, lymph node metastases (LNM) and distant metastases.Material and Methods: Mutation analysis was performed in 437 tissue samples from 204...

ea0049oc14.4 | Thyroid Cancer | ECE2017

Inverse relation between thyroid cancer incidence and threshold for thyroid surgery: a national population-based retrospective study

Decallonne Brigitte , den Bruel Annick Van , Nathalie Elaut , Schutter Harlinde De

Background: In Belgium, lower thyroid cancer incidence – most pronounced for microcancers (T1a) – is present in the North compared to the South. This variation is paralleled by differences in clinical practice: in the North less thyroid surgery is performed, more surgery is preceded by fine needle aspiration (FNA), and more patients with a final cancer diagnosis (2004–2006) underwent a presurgical FNA or a lymph node dissection (LND) at fist surgery.<p class...

ea0049oc14.5 | Thyroid Cancer | ECE2017

Dose aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classical papillary carcinoma?

Song Eyun , Ji Jeon Min , Kwon Hyemi , Park Suyeon , Oh Hye-Seon , Ryu Jin-Sook , Eun Song Dong , Young Kim Eui , Yong Kim Tae , Kee Shong Young , Bae Kim Won , Gu Kim Won

Background: Unlike excellent prognosis of classical papillary thyroid carcinoma (cPTC), certain pathological subtypes of aggressive variants of PTC (AV-PTC) are considered to have poor clinical outcome. However, the evidence of unfavorable outcome of AV-PTC is not clear because previous studies did not control other confounding factors contributed to clinical outcomes.Methods: This retrospective cohort study initially included 4339 patients with cPTC and...